Bermuda Consolidated Legislation

1.

The following substances and products, namely:—

(a)

ACETORPHINE

ALFENTANIL

ALLYLPRODINE

ALPHACETYLMETHADOL

ALPHAMEPRODINE

ALPHAMETHADOL

ALPHAPRODINE

ANILERIDINE

BENZETHIDINE

BENZYLMORPHINE (3-Benzylmorphine)

BETACETYLMETHADOL

BETAMEPRODINE

BETAMETHADOL

BETAPRODINE

BEZITRAMIDE

BUFOTENINE

CANNABINOL DERIVATIVES

CANNABINOL except where contained in Cannabis or
Cannabis resin

CARFENTANIL

CLONITAZENE

COCA LEAF

COCAINE

DESOMORPHINE

DEXTROMORAMIDE

DIAMORPHINE

DIAMPROMIDE

DIETHYLTHIAMBUTENE

DIFENOXIN (1-(3-cyano-3,3-diphenylpropyl)-4-
phenylpiperidine-4-carboxylic acid)

DIHYDROCODEINONE O-CARBOXYMETHYLOXIME

DIHYDROMORPHINE

DIMENOXADOLE

DIMEPHEPTANOL

DIMETHYLTHIAMBUTENE

DIOXAPHETYL BUTYRATE

DIPHENOXYLATE

DIPIPANONE

DROTEBANOL (3,4-dimethoxy-17-methylmor-
phinan-6,14-diol)

ECGONINE and any derivative of ecgonine which is
convertible to ecgonine or to cocaine

ETHYLMETHYLTHIAMBUTENE

ETICYCLIDINE

ETONITAZENE

ETORPHINE

ETOXERIDINE

FENTANYL

FURETHIDINE

HYDROCODONE

HYDROMORPHINOL

HYDROMORPHONE

HYDROXYPETHIDINE

ISOMETHADONE

KETOBEMIDONE

LEVOMETHORPHAN

LEVOMORAMIDE

LEVOPHENACYLMORPHAN

LEVORPHANOL

LOFENTANIL

LYSERGAMIDE

LYSERGIDE and other N-alkyl derivatives of lysergamide

MESCALINE

METAZOCINE

METHADONE

METHADYL ACETATE

METHYLAMINOREX

METHYLDESORPHINE

METHYLDIHYDROMORPHINE (6-methyldihydro-
morphine)

METOPON

MORPHERIDINE

MORPHINE

MORPHINE METHOBROMIDE, morphine n-oxide and
other pentavalent nitro-
gen morphine deriva- tives

MYROPHINE

N, N-DIETHYLTRYPTAMINE

N, N-DIMETHYLTRYPTAMINE

N-HYDROXYTENAMPHETAMINE (N-hydroxy MDA)

NICOMORPHINE (3,6-dinicotinoylmorphine)

NORACYMETHADOL

NORLEVORPHANOL

NORMETHADONE

NORMORPHINE

NORPIPANONE

OPIUM whether raw, prepared or medicinal

OXYCODONE

OXYMORPHONE

PETHIDINE

PHENADOXONE

PHENAMPROMIDE

PHENAZOCINE

PHENCYCLIDINE

PHENOMORPHAN

PHENOPERIDINE

PIMINODINE

PIRITRAMIDE

POPPY-STRAW and concentrate of poppy-straw

PROHEPTAZINE

PROPERIDINE (1-methyl-4-phenylpiperidine-4-
carboxylic acid isopropyl ester)

PSILOCIN

RACEMETHORPHAN

RACEMORAMIDE

RACEMORPHAN

ROLYCYCLIDINE

SUFENTANIL

TENOCYCLIDINE

THEBACON

THEBAINE

TILIDATE

TRIMEPERIDINE

4-BROMO-2,5-DIMETHOXY--METHYLPHENETHYLAMINE

4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE

4-CYANO-1-METHYL-4-PHENYLPIPERDINE

2,5 -DIMETHOXY-,4-DIMETHYLPHENETHYLAMINE

2-METHYL-3-MORPHOLINO-1,1-DIPHENYLPROPANECARBOXYLIC ACID

1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID

4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER (norpethidine)

(b)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c)

any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, -methylphenethylamine, and N-Alkyl -methylphenethylamine, or an N-alkyl -ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.

(d)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i)

by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii)

by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups

(iii)

by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv)

by substitution in the aniline ring with alkyl, alkoxy alkylenedioxy, halogeno or haloalkyl groups;

(v)

by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(e)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say.

(i)

by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii)

by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii)

by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv)

by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v)

by formation of a N-oxide or of a quaternary base.

2.

Any stereoisomeric form of a substance for the time being specified in paragraph 1 not being dextromethorphan or dextrorphan.

3.

Any ester or ether or a substance for the time being specified in paragraph 1 or 2 not being a substance for the time being specified in Part II of this Schedule.

4.

Any salt of a substance for the time being specified in any of paragraphs 1 to 3.

5.

Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4.

6.

Any preparation designed for administration by injection specified in any of paragraphs 1 to 3 of Part II of this Schedule

1.

The following substances and products, namely:—

(a)

ACETYLDIHYDROCODEINE

AMPHETAMINE

CANNABIS AND CANNABIS RESIN

CODEINE

DIHYDROCODEINE

ETHYLMORPHINE (3-ethylmorphine)

GLUTETHIMIDE

LEFETAMINE

MECLOQUALONE

METHAQUALONE

METHYLAMPHETAMINE

METHYLPHENIDATE

METHYLPHENOBARBITONE

NICOCODINE

NICODICODINE (6-nicotinoyldihydrocodeine)

NORCODEINE

PENTAZOCINE

PHENMETRAZINE

PHOLCODINE

PROPIRAM

(b)

any 5,5 disubstituted barbituric acid

2.

Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.

3.

Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4.

Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.

1.

The following substances and products, namely:—

ALPRAZOLAM

BENZPHETAMINE

BROMAZEPAM

BUPRENORPHINE

CAMAZEPAM

CATHINE

CATHINONE

CHLORDIAZEPOXIDE

CHLORPHENTERMINE

CLOBAZAM

CLONAZEPAM

CLORAZEPIC ACID

CLOTIAZEPAM

CLOXAZOLAM

DELORAZEPAM

DEXTROPROPOXYPHENE

DIAZEPAM

DIETHYLPROPION

ESTAZOLAM

ETHCHLORVYNOL

ETHINAMATE

ETHYL LOFLAZEPATE

FENCANFAMIN

FENETHYLLINE

FENPROPOREX

FLUDIAZEPAM

FLUNITRAZEPAM

FLURAZEPAM

HALAZEPAM

HALOXAZOLAM

KETAZOLAM

LOPRAZOLAM

LORAZEPAM

LORMETAZEPAM

MAZINDOL

MEDAZEPAM

MEFENOREX

MEPHENTERMINE

MEPROBAMATE

METHYPRYLONE

MIDAZOLAM

N-ETHYLAMPHETAMINE

NIMETAZEPAM

NITRAZEPAM

NORDIAZEPAM

OXAZEPAM

OXAZOLAM

PEMOLINE

PHENDIMETRAZINE

PHENTERMINE

PINAZEPAM

PIPRADROL

PRAZEPAM

PROPYLHEXEDRINE

PYROVALERONE

TEMAZEPAM

TETRAZEPAM

TRIAZOLAM

2.

Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule, not being phenylpropanolamine.

3.

Any salt of a substance for the time being specified in paragraphs 1 or 2 of this Part of this Schedule.

4.

Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.